SCHEMBL1127899

SCHEMBL1127899

O[C@@H]1C2CCC(C2)[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127898 1.00
SCHEMBL10035514 1.00
SCHEMBL278804 1.00
SCHEMBL26258402 1.00
SCHEMBL16539999 0.96 LMNA (0.39)
SCHEMBL15973517 0.88 CYP2C9 (0.53)
SCHEMBL17491564 0.87 CYP2C9 (0.32)
SCHEMBL771200 0.77 CYP2C9 (0.35)
SCHEMBL24477655 0.77
SCHEMBL8417560 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137554-A1 SHAPE MEMORY CYANATE ESTER COPOLYMERS CORNERSTONE RESEARCH GROUP, INC. 2010-06-03 US claimed
EP-1979397-A4 SHAPE MEMORY CYANATE ESTER COPOLYMERS CORNERSTONE RES GROUP INC (US) 2009-04-08 EP claimed
EP-1979397-A2 SHAPE MEMORY CYANATE ESTER COPOLYMERS CORNERSTONE RESEARCH GROUP, INC. (US) 2008-10-15 EP claimed
WO-2008051241-A2 SHAPE MEMORY CYANATE ESTER COPOLYMERS CORNERSTONE RESEARCH GROUP, INC. (US) 2008-05-02 WO claimed
US-7250157-B2 Dermatological compositions and methods APPLIED GENETICS INCORPORATED DERMATICS (US) 2007-07-31 US claimed
US-20060120976-A1 Dermatological compositions and methods APPLIED GENETICS INCORPORATED DERMATICS (US) 2006-06-08 US claimed
EP-1072430-B1 Ink jet printing process EASTMAN KODAK CO (US) 2005-12-14 EP claimed
US-6955804-B2 Dermatological compositions and methods APPLIED GENETICS INCORPORATED DEMATICS (US) 2005-10-18 US claimed
EP-0957903-B1 DIOLS OF NORBORNENE AND NORBORNANE COMPOUNDS FOR TREATING PIGMENTATION DISORDERS, NEURODEGENERATIVE DISEASES OR PROLIFERATIVE SKIN DISORDERS APPLIED GENETICS INC DERMATICS (US) 2005-08-10 EP claimed
US-20040067209-A1 Dermatological compositions and methods APPLIED GENETICS INCORPORATED DERMATICS 2004-04-08 US claimed
EP-0957903-A4 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS INC (US) 2002-10-09 EP claimed
US-20020141952-A1 Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues APPLIED GENETICS INCORPORATED DERMATICS 2002-10-03 US claimed
WO-2002051395-A1 TREATMENT OF NEURODEGENERATIVE DISEASES CODON PHARMACEUTICALS, INC. (US) 2002-07-04 WO claimed
US-6294585-B1 ADMINISTERING NORBORNANE DIOL/TRIOL OR NORBORNENE DIOL/TRIOL DERIVATIVES FOR INCREASING DIFFERENTIATION OF MAMMALIAN NEURONAL CELLS APPLIED GENETICS INCORPORATED DERMATICS 2001-09-25 US claimed
US-6280026-B1 Ink jet printing process EASTMAN KODAK COMPANY 2001-08-28 US claimed
EP-1072430-A2 Ink jet printing process EASTMAN KODAK COMPANY (US) 2001-01-31 EP claimed
EP-0957903-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS Codon Pharmaceuticals, Inc. (US) 1999-11-24 EP claimed
US-5990177-A CYCLIC AND ACYCLIC MONO-, DI- AND TRIALCOHOLS AS STIMULANTS TO TREAT DISEASES MEDIATED BY DEFICIENCIES IN THE NITRIC OXIDE/CYCLIC GUANOSINE MONOPHOSPHATE/PROTEIN KINASE G SIGNAL TRANSDUCTION PATHWAY; CARDIOVASCULAR; SKIN; NERVOUS SYSTEM CODON PHARMACEUTICALS, INC. (US) 1999-11-23 US claimed
WO-1998055085-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS, INC. (US) 1998-12-10 WO claimed
WO-1998011882-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS, INC. (US) 1998-03-26 WO claimed